Want to join the conversation?
David Risinger of Morgan Stanley asks for an update on Botox and its opportunities. $AGN said it is only halfway through the life and growth of Botox, both aesthetically and therapeutically. The company sees this as a pipeline and a product which will be a key growth driver for $AGN for the next decade or more.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!